NCT07292961 Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma
| NCT ID | NCT07292961 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Scleroderma |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-12-04 |
| Primary Completion | 2027-12-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-12-04 with a primary completion date of 2027-12-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with scleroderma.
Eligibility Criteria
\*For a child diagnosed with scleroderma\* Inclusion Criteria: * Cases diagnosed with scleroderma, * Cases aged 7-18 years will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Cases that are not willing to participate in the study will be excluded. * History of developmental delay * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study \*For adults diagnosed with scleroderma\* Inclusion Criteria: * Individuals diagnosed with scleroderma, * Individuals over the age of 18 will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Individuals who are not willing to participate in the study will be excluded. * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07292961 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, studying Scleroderma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07292961 currently recruiting?
Yes, NCT07292961 is actively recruiting participants. Contact the research team at orkuntf@gmail.com for enrollment information.
Where is the NCT07292961 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07292961 clinical trial?
NCT07292961 is sponsored by Hacettepe University. The trial plans to enroll 48 participants.